Sunlight Review

Sunlight: a flat-rate compounded GLP-1 service built to undercut brand-name prices

Sunlight is a telehealth platform that does one thing and tries to do it cheaply: it puts you on compounded semaglutide or compounded tirzepatide for a single flat monthly fee that bundles in the medication, your clinician visits, and shipping. There are no brand-name pens here and no à la carte add-ons; the whole pitch is that one predictable charge replaces the thousand-dollar-plus monthly bills people quote for Ozempic or Zepbound. If you already know you want a compounded GLP-1 and you mainly care about a low, all-inclusive number, Sunlight is squarely aimed at you. If you want a name-brand prescription or a long paper trail on the company behind the service, it is not.

How the flat monthly price works

Sunlight charges the same rate regardless of your dose ("same price for every dose," in its own words), which helps because most GLP-1 patients titrate upward over months and many competitors raise the price as the dose climbs. Under its current fall promo, compounded semaglutide is advertised at $88 a month (starting dose) and compounded tirzepatide at $157, with a promise of the same price forever; its product menu still says "starting at $179" for each. That semaglutide rate is well under our category median of $179, which makes Sunlight one of the cheaper compounded options on headline price. Each flat rate is meant to include your prescription, unlimited telehealth visits, and free 1-2 day shipping with, in their phrasing, "no hidden fees."

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

Go in knowing one caveat. The homepage runs these prices under a fall promo banner. It also promises a locked rate in its own words: "Same price forever." Yet the product menu on that page still lists both medications as starting at a higher price, and the large "Reg" figures shown next to each product are list-price comparisons rather than what anyone pays. The promise of a locked price is a good sign, but the mixed signals on the page are worth clearing up before you pay.

• Confirm your rate at checkout: check that the price you are charged matches the advertised flat rate, and ask that it stays locked.
• The dose-flat structure is a plus: your bill shouldn't rise as you titrate up, unlike step-up pricing elsewhere.
• Ignore the "Reg" figures: they compare against brand-name list prices, not a Sunlight price you would pay later.

The medications and how they're dispensed

Sunlight offers two product lines, both compounded: semaglutide (the molecule in Ozempic and Wegovy) and tirzepatide (the molecule in Mounjaro and Zepbound). Compounded versions are mixed by a pharmacy rather than manufactured by the brand, which is how the price gets so low, but it also means you are not getting the FDA-approved branded pen. For a daily tablet, Vaylen offers oral semaglutide at one price for every dose and charges only after a clinician approves you. That is a legitimate trade-off, not a scam, and it is the same trade-off most low-cost GLP-1 services make. Sunlight's FAQ names six partner pharmacies (Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills), which is more than many budget services disclose. It does not say which one fills a given order, so ask if you want to look up that pharmacy's credentials.

The unlimited-visit bundle, and where Sunlight stays vague

Sunlight's main differentiator is the unlimited-visit bundle. Many flat-fee competitors cap your clinician contact or charge for extra visits; Sunlight folds unlimited telehealth support into the base price, which matters during the first few months when dose adjustments and side-effect questions come up most. A patient testimonial on the site reports losing 31 pounds in four months on tirzepatide after previously paying more than twelve hundred dollars a month elsewhere. That is one anecdote, not data, but it captures who the service is for.

Against that, Sunlight is quiet about itself in other ways. The legal entity name and state of incorporation aren't disclosed, and while it says it serves all 50 states, it adds that some services vary by state. It also runs multiple A/B-tested marketing funnels (a BMI-led path and a separate tirzepatide path with cookie-based routing), which is common in direct-to-consumer telehealth but a sign the operation is growth-and-conversion focused. None of this is disqualifying, but it leaves you taking more on faith than you should have to. In Utah, Potere Health MD is a physician-led clinic with a named lead doctor and no subscription model.

Trust, safety, and medical oversight

The strongest trust signal Sunlight carries is LegitScript certification, an independent program that vets telehealth pharmacies and prescribers for legal compliance, which not every budget GLP-1 site bothers to obtain. Sunlight also has no FDA warning letters against it. So the floor here is decent: a certified platform connecting you to licensed clinicians, with no regulatory black marks. The ceiling is held down by the disclosure gaps: an undisclosed corporate entity and no word on which partner pharmacy fills your order. You can read how we weigh these signals in our scoring methodology.

Who should choose Sunlight

• Cost-driven patients who specifically want a compounded GLP-1 and value one predictable, dose-flat monthly bill.
• People who titrate slowly and will use the unlimited telehealth visits rather than a one-and-done prescription.
• Anyone replacing a much pricier brand-name regimen who wants a low, locked monthly price.

Who should skip it

• Patients who want a brand-name Ozempic, Wegovy, Mounjaro, or Zepbound prescription, since Sunlight is compounded only.
• Anyone who needs to know the company's legal entity and the exact dispensing pharmacy before they'll hand over a credit card.
• People who are uneasy that the homepage shows a promo price and a higher "starting at" price side by side.

Bottom line

Sunlight is a credible, LegitScript-certified, low-cost route to compounded semaglutide or tirzepatide, and its dose-flat, unlimited-visit bundle beats services that nickel-and-dime you as your dose climbs. The reservations are about transparency, not legitimacy: you don't know who legally operates the service or which of its named pharmacies fills your order, and the homepage mixes a promo price with a higher menu price. Confirm that you are charged the advertised fall promo price of $88 (starting dose) at checkout rather than the $179 menu price, and Sunlight is a reasonable pick for budget-focused compounded GLP-1 shoppers.